Update on Recurrent Focal Segmental Glomerulosclerosis in Kidney Transplantation
- 1 December 2020
- journal article
- review article
- Published by S. Karger AG in Nephron
- Vol. 144 (Suppl. 1), 65-70
- https://doi.org/10.1159/000510748
Abstract
Background: Focal segmental glomerulosclerosis (FSGS) is a clinicopathological syndrome characterized by nephrotic-range proteinuria with high incidence of progression to end-stage renal disease (ESRD). In primary FSGS, 40–60% of patients develop ESRD within 10–20 years. Summary: Recurrence of FSGS after kidney transplantation is frequent and is associated with poor allograft survival. The risk factors for recurrent FSGS include onset of FSGS during childhood, rapid progression of primary FSGS to ESRD, history of recurrent FSGS in previous allograft, and diffuse mesangial hypercellularity or collapsing variant of FSGS in the native kidney. The early histological findings of recurrent FSGS consist of unremarkable glomerular changes on light microscopy but significant podocyte effacement on electron microscopy; the loss of foot processes with eventual dropout of podocytes leads to the development of segmental lesions in the glomerulus. Experimental and clinical data suggest the existence of circulating permeability factors, such as soluble urokinase-type plasminogen activator receptor (suPAR), cardiotrophin-like cytokine factor-1 (CLCF-1), CD40 axis, and apolipoprotein A-Ib (ApoA-Ib), in the pathogenesis of recurrent FSGS. These biomarkers including circulating permeability factors may facilitate earlier diagnosis of FSGS posttransplant and may guide in the development of novel therapies that may be more effective and improve long-term outcomes in kidney transplantation. Key Messages: Several studies have suggested the possible circulating permeability factors, such as suPAR, CLCF-1, CD40 axis, and ApoA-Ib, in the pathogenesis and disease progression of FSGS and recurrent FSGS. Further studies should be performed to elucidate the true essential biomarker(s) associated with the onset and progression of FSGS as well as recurrent FSGS.Keywords
This publication has 27 references indexed in Scilit:
- A multicenter cross-sectional study of circulating soluble urokinase receptor in Japanese patients with glomerular diseaseKidney International, 2014
- A Form of Apolipoprotein A-I Is Found Specifically in Relapses of Focal Segmental Glomerulosclerosis Following TransplantationAmerican Journal of Transplantation, 2012
- Soluble urokinase receptor and focal segmental glomerulosclerosisCurrent Opinion in Nephrology and Hypertension, 2012
- Circulating urokinase receptor as a cause of focal segmental glomerulosclerosisNature Medicine, 2011
- Recurrence of nephrotic syndrome after transplantation in a mixed population of children and adults: course of glomerular lesions and value of the Columbia classification of histological variants of focal and segmental glomerulosclerosis (FSGS)Nephrology Dialysis Transplantation, 2009
- Fidelity and Evolution of Recurrent FSGS in Renal AllograftsJournal of the American Society of Nephrology, 2008
- Modification of kidney barrier function by the urokinase receptorNature Medicine, 2007
- New Insights into the Pathogenesis and the Therapy of Recurrent Focal GlomerulosclerosisAmerican Journal of Transplantation, 2005
- Circulating Factor Associated with Increased Glomerular Permeability to Albumin in Recurrent Focal Segmental GlomerulosclerosisThe New England Journal of Medicine, 1996
- Recurrent focal glomerulosclerosis: Natural history and response to therapyThe American Journal of Medicine, 1992